The Optimal Selection of Radiotherapy Treatment for Hepatocellular Carcinoma

키워드

참고문헌 (83)

1. Parkin DM, "lobal cancer statistics, 2002", CA Cancer J Clin, 55, pp.74~108 (2005)
2. Bruix J, "Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma", Hepatology, 42, pp.1208~1236 (2005)
3. Cochrane AM, "Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma", Cancer, 40, pp.609~614 (1977)
4. Ingold JA, "Radiation hepatitis", Am J Roentgenol Radium Ther Nucl Med, 93, pp.200~208 (1965)
5. Lawrence TS, "An application of dose volume histograms to the treatment of intrahepatic malignancies with radiation therapy", Int J Radiat Oncol Biol Phys, 19, pp.1041~1047 (1990)
6. Lawrence TS, "The use of 3-D dose volume analysis to predict radiation hepatitis", Int J Radiat Oncol Biol Phys, 23, pp.781~788 (1992)
7. Robertson JM, "A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases", Int J Radiat Oncol Biol Phys, 39, pp.1087~1092 (1997)
8. Seong J, "Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 43, pp.393~397 (1999)
9. Shim SJ, "Local radiotherapy as a complement to incomplete transcatheter arterial chemoembolization in locally advanced hepatocellular carcinoma", Liver Int, 25, pp.1189~1196 (2005)
10. Park W, "Local radiotherapy for patients with unresectable hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 61, pp.1143~1150 (2005)
11. Park JW, "Practice guideline for diagnosis and treatment of hepatocellular carcinoma", Korean J Hepatol, 10, pp.88~98 (2004)
12. Korean Liver Cancer Study Group and National Cancer Center, "Practice guidelines for management of hepatocellular carcinoma 2009", Korean J Hepatol, 15, pp.391~423 (2009)
13. Bruix J, "Focus on hepatocellular carcinoma", Cancer Cell, 5, pp.215~219 (2004)
14. Izumi R, "Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection", Gastroenterology, 106, pp.720~727 (1994)
15. Okuda K, "Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients", Cancer, 56, pp.918~928 (1985)
16. "A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators", Hepatology, 28, pp.751~755 (1998)
17. Kudo M, "Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)", J Gastroenterol, 38, pp.207~215 (2003)
18. Seong J, "Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapy", Int J Radiat Oncol Biol Phys, 67, pp.1037~1042 (2007)
19. 박희철, "Clinical results of 3-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma in the cirrhotic patients", HEPATOLOGY RESEARCH, 27, pp.30~35 (2003), BLACKWELL PUBLISHING
20. Cheng SH, "A pilot study of three-dimensional conformal radiotherapy in unresectable hepatocellular carcinoma", J Gastroenterol Hepatol, 14, pp.1025~1033 (1999)
21. Pressman D, "The use of paired labeling in the determination of tumor-localizing antibodies", Cancer Res, 17, pp.845~850 (1957)
22. Tang ZY, "Radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma with reference to second-look resection", Cancer, 65, pp.211~215 (1990)
23. Order SE, "Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study", J Clin Oncol, 3, pp.1573~1582 (1985)
24. Order S, "A randomized prospective trial comparing full dose chemotherapy to 131I antiferritin: an RTOG study", Int J Radiat Oncol Biol Phys, 20, pp.953~963 (1991)
25. Carr BI, "Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients", Liver Transpl, 10(2 Suppl 1), pp.S107~S110 (2004)
26. Geschwind JF, "Yttrium-90 microspheres for the treatment of hepatocellular carcinoma", Gastroenterology, 127(5 Suppl 1), pp.S194~S205 (2004)
27. Salem R, "Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis", J Vasc Interv Radiol, 15, pp.335~345 (2004)
28. Kulik LM, "Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis", Hepatology, 47, pp.71~81 (2008)
29. Kim JK, "Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166", chitosan complex (Milican) for the treatment of small hepatocellular carcinoma, 2006, pp.12, 543~548
30. Sohn JH, "Phase II Study of Transarterial Holmium-166-Chitosan Complex Treatment in Patients with a Single, Large Hepatocellular Carcinoma", Oncology, 76(1), pp.1~9
31. Intensity Modulated Radiation Therapy Collaborative Working Group, "Intensity-modulated radiotherapy: current status and issues of interest", Int J Radiat Oncol Biol Phys, 51, pp.880~914 (2001)
32. Cheng JC, "Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease", Int J Radiat Oncol Biol Phys, 56, pp.229~234 (2003)
33. Mackie TR, "Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy", Med Phys, 20, pp.1709~1719 (1993)
34. Mackie TR, "Tomotherapy", Semin Radiat Oncol, 9, pp.108~117 (1999)
35. Cattaneo GM, "Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLC", Radiother Oncol, 88, pp.310~318 (2008)
36. Widesott L, "Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation", Int J Radiat Oncol Biol Phys, 72, pp.589~596 (2008)
37. Lee IJ, "Selection of the optimal radiotherapy technique for locally advanced hepatocellular carcinoma", Jpn J Clin Oncol, 41, pp.882~889 (2011)
38. 박희철, "Dose-response relationship in local radiotherapy for hepatocellular carcinoma", INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 54(1), pp.150~155, ELSEVIER SCIENCE INC
39. 박희철, "Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: A retrospective study of 158 patients", INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 55, pp.329~336, ELSEVIER SCIENCE INC
40. 김진호, "Preliminary Result of Stereotactic Body Radiotherapy as a Local Salvage Treatment for Inoperable Hepatocellular Carcinoma", JOURNAL OF SURGICAL ONCOLOGY, 102(3), pp.209~214, WILEY-LISS
41. Louis C, "Stereotactic radiotherapy of hepatocellular carcinoma: preliminary results", Technol Cancer Res Treat, 9, pp.479~487 (2010)
42. Tse RV, "Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma", J Clin Oncol, 26, pp.657~664 (2008)
43. Cárdenes HR, "Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma", Clin Transl Oncol, 12, pp.218~225 (2010)
44. Cárdenes HR, "Role of stereotactic body radiotherapy in the management of primary hepatocellular carcinoma. Rationale, technique and results", Clin Transl Oncol, 11, pp.276~283 (2009)
45. Dawson LA, "Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control", Int J Radiat Oncol Biol Phys, 62, pp.1247~1252 (2005)
46. Chiba T, "Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients", Clin Cancer Res, 11, pp.3799~3805 (2005)
47. Hata M, "Proton beam therapy for hepatocellular carcinoma with limited treatment options", Cancer, 107, pp.591~598 (2006)
48. Nakayama H, "Proton beam therapy for hepatocellular carcinoma: the University of Tsukuba experience", Cancer, 115, pp.5499~5506 (2009)
49. Bush DA, "High-dose proton beam radiotherapy of hepatocellular carcinoma: preliminary results of a phase II trial", Gastroenterology, 127(5 Suppl 1), pp.S189~S193 (2004)
50. Kawashima M, "Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma", J Clin Oncol, 23, pp.1839~1846 (2005)
51. Llovet JM, "Hepatocellular carcinoma", Lancet, 362, pp.1907~1917 (2003)
52. Bruix J, "Chemoembolization for hepatocellular carcinoma", Gastroenterology, 127(5 Suppl 1), pp.S179~S188 (2004)
53. Matsui O, "Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization", Radiology, 188, pp.79~83 (1993)
54. Miyayama S, "Ultraselective transcatheter arterial chemoembolization with a 2-f tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil", J Vasc Interv Radiol, 18, pp.365~376 (2007)
55. 강기문, "STEREOTACTIC BODY RADIOTHERAPY FOR PATIENTS WITH UNRESECTABLE PRIMARY HEPATOCELLULAR CARCINOMA: DOSE-VOLUMETRIC PARAMETERS PREDICTING THE HEPATIC COMPLICATION", INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 78(0), pp.1073~1080 (2010), American Society for Radiation Oncology
56. Andolino DL, "Stereotactic body radiotherapy for primary hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 81, pp.e447~e453 (2011)
57. Takeda A, "Hypofractionated stereotactic radiotherapy with and without transarterial chemoembolization for small hepatocellular carcinoma not eligible for other ablation therapies: preliminary results for efficacy and toxicity", Hepatol Res, 38, pp.60~69 (2008)
58. Lo CM, "Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma", Hepatology, 35, pp.1164~1171 (2002)
59. Llovet JM, "Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival", Hepatology, 37, pp.429~442 (2003)
60. Sakurai M, "Transcatheter chemo-embolization effective for treating hepatocellular carcinoma. A histopathologic study", Cancer, 54, pp.387~392 (1984)
61. Yu YQ, "Experience with liver resection after hepatic arterial chemoembolization for hepatocellular carcinoma", Cancer, 71, pp.62~65 (1993)
62. Yasuda S, "Radiotherapy for large hepatocellular carcinoma combined with transcatheter arterial embolization and percutaneous ethanol injection therapy", Int J Oncol, 15, pp.467~473 (1999)
63. Guo WJ, "Evaluation of combined therapy with chemoembolization and irradiation for large hepatocellular carcinoma", Br J Radiol, 73, pp.1091~1097 (2000)
64. Chia-Hsien Cheng J, "Unresectable hepatocellular carcinoma treated with radiotherapy and", or chemoembolization, 2001, pp.96, 243~252
65. Zeng ZC, "A comparison of chemoembolization combination with and without radiotherapy for unresectable hepatocellular carcinoma", Cancer J, 10, pp.307~316 (2004)
66. Koom WS, "Is local radiotherapy still valuable for patients with multiple intrahepatic hepatocellular carcinomas?", Int J Radiat Oncol Biol Phys, 77, pp.1433~1440 (2010)
67. Llovet JM, "Sorafenib in advanced hepatocellular carcinoma", N Engl J Med, 359, pp.378~390 (2008)
68. Cheng AL, "Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebocontrolled trial", Lancet Oncol, 10, pp.25~34 (2009)
69. Ben-Josef E, "Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies", J Clin Oncol, 23, pp.8739~8747 (2005)
70. Llovet JM, "Prognosis of hepatocellular carcinoma: the BCLC staging classification", Semin Liver Dis, 19, pp.329~338 (1999)
71. Yamada K, "Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 57, pp.113~119 (2003)
72. Zeng ZC, "A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and", or inferior vena cava tumor thrombus, 2005, pp.61, 432~443
73. Tazawa J, "Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocel lular carcinoma with extensive portal vein involvement", J Gastroenterol Hepatol, 16, pp.660~665 (2001)
74. Ishikura S, "Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus", Am J Clin Oncol, 25, pp.189~193 (2002)
75. Kim DY, "Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma", Cancer, 103, pp.2419~2426 (2005)
76. Han KH, "Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis", Cancer, 113(5), pp.995~1003
77. Lin CS, "Treatment of portal vein tumor thrombosis of hepatoma patients with either stereotactic radiotherapy or three-dimensional conformal radiotherapy", Jpn J Clin Oncol, 36, pp.212~217 (2006)
78. Cha HJ, "Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for locally advanced hepatocellular carcinoma", J Korean Soc Ther Radiol Oncol, 28, pp.52~ (2010)
79. Sang Min Yoon, "Radioresponse of Hepatocellular Carcinoma-Treatment of Lymph Node Metastasis", Cancer Research and Treatment, 36(1), pp.79~84 (2004), 대한암학회
80. Seong J, "Radiotherapy for painful bone metastases from hepatocellular carcinoma", Liver Int, 25, pp.261~265 (2005)
81. Nakamura N, "A retrospective study of radiotherapy for spinal bone metastases from hepatocellular carcinoma (HCC)", Jpn J Clin Oncol, 37, pp.38~43
82. Choi HJ, "Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC", J Neurooncol, 91, pp.307~313 (2009)
83. McIntosh A, "Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma", Cancer, 115, pp.5117~5125 (2009)

관련 논문AI추천